Unique Gifts

Tuesday, June 28, 2005

All drugs containing PHENYLPROPANOLAMINE are being recalled.
You may want to try calling the 800 number listed on most drug boxes and inquire about a REFUND. Please read this CAREFULLY. Also, please pass this on to everyone you know. STOP TAKING anything containing this ingredient. It has been linked to increased hemorrhagic stroke (bleeding in brain) among women ages 18-49 in the three days after starting use of medication. Problems were not found in men, but the FDA recommended that everyone (even children) seek alternative medicine.
The following medications contain Phenylpropanolamine:
Acutrim Diet Gum Appetite Suppressant
Acutrim Plus Dietary Supplements
Acutrim Maximum Strength Appetite Control
Alka-Seltzer Plus Children's Cold Medicine Effervescent
Alka-Seltzer Plus Cold medicine (cherry or orange)<>Alka-Seltzer Plus Cold Medicine Original Alka-Seltzer Plus Cold & Cough Medicine Effervescent
Alka-Seltzer Plus Cold & Flu Medicine
Alka-Seltzer Plus Cold & Sinus Effervescent
Alka Seltzer Plus Night-Time Cold Medicine
BC Allergy Sinus Cold Powder
BC Sinus Cold Powder
Comtrex Flu Therapy & Fever Relief
Day & Night Contac 12-Hour Cold Capsules
Contac 12 Hour Caplets
Coricidin D Cold, Flu & Sinus
Dexatrim Caffeine Free
Dexatrim Extended Duration
Dexatrim Gelcaps
Dexatrim Vitamin C/Caffeine Free
Dimetapp Cold & Allergy Chewable Tablets
Dimetapp Cold & Cough Liqui-Gels
Dimetapp DM Cold & Cough Elixir
Dimetapp Elixir
Dimetapp 4 Hour Liquid Gels
Dimetapp 4 Hour Tablets
Dimetapp 12 Hour Extentabs Tablets
Naldecon DX Pediatric Drops
Permathene Mega-16
Robitussin CF
Tavist-D ! 12 Hour Relief of Sinus & Nasal Congestion
Triaminic DM Cough Relief
Triaminic Expectorant Chest & Head
Triaminic Syrup Cold & Allergy
Triaminic Triaminicol Cold & Cough .... I just found out and called the 800# on the container for Triaminic and they informed me that they are voluntarily recalling the following medicines because of a certain ingredient that is causing strokes and seizures in children: Orange 3D Cold &amp; Allergy Cherry (Pink) 3D Cold & Cough Berry 3D Cough Relief Yellow 3D Expectorant They are asking you to call them at 800-548-3708 with the lot number on the box so they can send you postage for you to send it back to them, and they will also issue you a refund. If you know of anyone else with small children, PLEASE PASS THIS ON. THIS IS SERIOUS STUFF! DO PASS ALONG TO ALL ON YOUR MAILING LIST so people are informed. They can then pass it along to their families. To confirm these findings please take time to check the following: www.fda.gov/cder/drug/infopage/ppa

1 Comments:

  • At 5:53 AM, Blogger lisagonzo0879 said…

    St0ck For Your Review - FCPG

    Current Profile
    Faceprint Global Solutions (FCPG)
    Current Price $0.15

    A U.S. based-company dedicated to the goal of
    bringing effective security solutions to the marketplace.

    With violent and white-collar terrorism on the rise,
    companies are starving for innovative security solutions.


    FCPG is set to bring hot new security solutions to
    the industry, with currently over 40 governmental and
    non-governmental contracts, being negotiated.


    Please Review Exactly What this Company Does.

    Why consider Faceprint Global Solutions (FCPG)?

    Faceprint Global Solutions (FCPG) holds the exclusive
    marketing rights from Keyvelop, to sell the world�s
    leading encryption technology to be distributed directly
    to the Healthcare industry in North America.

    Faceprint Global Solutions has completed its biometric
    software that recognizes facial features of individuals
    entering and leaving through airports, ship yards, banks,
    large buildings, etc.

    FCPG acquired Montreal-based Apometrix Technologies,
    which enhances the companies mission of being a
    full-service provider to the multi-application smart
    card industry. The North American market appears ready
    for significant expansion of price-competitive, proven,
    multi-application solutions on smart cards. Apometrix's
    forecast of over 300 customers and sales of more than $50
    million in North America over the next five years, appears
    very realistic, according to company management.


    Faceprint Global Solutions is currently in contract negotiations
    with over 40 governmental agencies and businesses seeking to use
    their encryption, biometric, and smart-card technologies.

    Breaking News for Faceprint Global Solutions (FCPG)

    Faceprint Global Solutions (FCPG) is pleased to announce that
    IBM will now offer the world�s leading encryption software to
    its major Healthcare clients in North America.


    With FCPG owning the exclusive North American rights to distribute
    the worlds leading encryption and transmission software developed by
    Keyvelop, FCPG is poised to capture large volumes of sales generated
    by customers currently using IBM�s software in the healthcare and other
    industries.


    �This is a very positive move for FCPG and for Keyvelop,� said FCPG
    CEO Pierre Cote. �We are very happy about the decision to go with IBM.
    This is a continuation of the progress made by everyone associated
    with FCPG and its partners.�

    Buell Duncan, IBM's general manager of ISV & Developer Relations commented,
    �Collaborating with Keyvelop will ensure that we develop open solutions that
    are easy to maintain and cost effective for our customers in the healthcare
    and life sciences industry.�

    Among other things, this new software technology which is currently
    being used by a number of European healthcare companies, is used to
    send any file, regardless of format or size. Encryption keys, evidence
    of transmission integrity with fingerprint calculation, time-stamping
    of all actions and status record updating, pre-checking sender and
    receiver identities, validating file opening dates are part of Keyvelop features.

    About FacePrint Global Solutions, Inc.

    FCPG operates a business, which develops and delivers a variety of
    technology solutions, including biometric software applications on
    smart cards and other support mediums (apometric solutions). FCPG�s
    products provide biometric solutions for identity authentication and a
    host of smart card- and biometrics-related hardware peripherals and
    software applications. Apometrix, FCPG�s wholly-owned subsidiary,
    combines on-card or in-chip multi-application management solutions
    with best-of-breed �in-card matching� biometrics. Keyvelop�s secure
    digital envelope solution and Apometrix�s on-card biometrics work
    together to produce the winning combination in the fields of security,
    traceability and identity management.

    Conclusion:

    The examples above show the Awesome, Earning Potential of little known
    Companies That Explode onto Investor�s Radar Screens. This sto,ck will
    not be a Secret for long. Then You May Feel the Desire to Act Right Now!
    And Please Watch This One Trade!

    GO FCPG!

    Disclaimer:
    Information within this email contains "forward |ooking statements" within
    the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of
    the Securities Exchange Act of 1934. Any statements that express or involve
    discussions with respect to predictions, expectations, beliefs, plans,
    projections, objectives, goals, assumptions or future events or performance
    are not statements of historical fact and may be "forward |ooking statements".
    "Forward |ooking statements" are based on expectations, estimates and projections
    at the time the statements are made that involve a number of risks and uncertainties
    which could cause actual results or events to differ materially from those presently
    anticipated. We were paid a sum of three thousand USD to disseminate this information
    from ir marketing. Forward loking statements in this action may be identified through
    the use of words such as "projects", "foresee", "expects", "will", "anticipates",
    "estimates", "believes", "understands" or that by statements indicating
    certain actions "may", "could", or "might" occur. Risk factors include
    general economic and business conditions, the ability to acquire and develop
    specific projects, the ability to fund operations and changes in consumer and
    business consumption habits and other factors over which the company has little
    or no control. The publisher of this newsletter does not represent that the
    information contained herein are true and correct.

     

Post a Comment

<< Home